However, the findings of these studies cannot fully explain the mechanisms underlying the evasion of VEGFR inhibitor treatment in RCC, because some studies have found that continued growth of sunitinib-resistant tumors occurred independently of tumor microvessel density (MVD) [13]. Here, KDR is linked to renal cell carcinoma.